Dani Reiss - 25 Jan 2022 Form 4 Insider Report for Casper Sleep Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 25 Jan 2022
Net transaction value: -$924,980
SEC form: 4
Accepted by SEC: 26 Jan 2022, 15:09:07 UTC
Prior SEC filing: 18 Jan 2022
Source filing: View source filing
Reporting owner signature: /s/ Michael Monahan, Attorney-in-Fact for Dani Reiss

Key filing fact

Dani Reiss filed Form 4 for Casper Sleep Inc. on 26 Jan 2022.

Key facts

This page summarizes Dani Reiss's Form 4 filing for Casper Sleep Inc..
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 26 Jan 2022, 15:09.

Change

Previous filing in this sequence was filed on 18 Jan 2022.
Current net transaction value: -$924,980.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CSPR transaction

Common Stock

Disposed to Issuer

Transaction value: $300,274
Shares: -43,518
Change %: -100%
Price: $6.90
Shares after: 0
Date: 25 Jan 2022
Ownership: Direct
Footnotes: F1, F2

CSPR transaction

Common Stock

Disposed to Issuer

Transaction value: $624,705
Shares: -90,537
Change %: -100%
Price: $6.90
Shares after: 0
Date: 25 Jan 2022
Ownership: See Footnote
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CSPR transaction Derivative

Stock Option

Disposed to Issuer

Transaction value: $0
Shares: -25,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 25 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 25,000
Exercise price: $15.90
Footnotes: F4, F5

CSPR transaction Derivative

Stock Option

Disposed to Issuer

Transaction value: $0
Shares: -60,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 25 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 60,000
Exercise price: $15.90
Footnotes: F5, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Dani Reiss is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 6 footnotes

Footnote F1

Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2021 (the "Merger Agreement"), by and among Casper Sleep Inc. (the "Issuer"), Marlin Parent, Inc. and Marlin Merger Sub, Inc. ("Merger Sub"). On January 25, 2022, upon the closing of the merger of Merger Sub with and into the Issuer (the "Merger") contemplated by the Merger Agreement, each share of common stock of the Issuer, par value $0.000001 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $6.90 (the "Merger Consideration"), without interest, subject to applicable withholding taxes.

Footnote F2

In accordance with the Merger Agreement, each restricted stock unit award ("RSU Award") of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was cancelled and converted into the right to receive an amount in cash, subject to applicable withholding taxes, equal to the Merger Consideration multiplied by the number of shares of Issuer common stock subject to such RSU Award.

Footnote F3

The shares reported herein were held by DTR LLC. The Reporting Person indirectly controls DTR LLC and therefore may be deemed to hold voting and dispositive power with respect to these shares. The Reporting Person disclaims beneficial ownership of the shares held by DTR LLC except to the extent of his pecuniary interest therein, if any.

Footnote F4

The options were fully vested and exercisable.

Footnote F5

In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger.

Footnote F6

The options provided for vesting in equal monthly installments over a four year period commencing on April 25, 2019, and would have been fully vested and exercisable on March 25, 2023.